CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-28 | Mayer Arie Director | Grant or award | +12,000 | 18,000 | ||
| 2022-07-28 | Derovan Netanel Chief Legal Officer | Grant or award | +30,000 | 48,000 | ||
| 2022-07-28 | Kidron Miriam Chief Scientific Officer | Grant or award | +34,000 | 217,666 | ||
| 2022-07-28 | Kidron Miriam Chief Scientific Officer | Grant or award | +84,000 | 301,666 | ||
| 2022-07-28 | KIDRON NADAV President and CEO | Grant or award | +34,000 | 964,729 | ||
| 2022-07-28 | KIDRON NADAV President and CEO | Grant or award | +126,000 | 1,090,729 | ||
| 2022-07-28 | Hexter Joshua COO & CBO | Grant or award | +42,000 | 166,333 | ||
| 2022-07-28 | Sank Leonard Director | Grant or award | +12,000 | 18,000 | ||
| 2022-07-28 | Silberman David Chief Financial Officer | Grant or award | +39,000 | 108,000 | ||
| 2022-07-28 | Rabinowitz Michael Chief Commercial Officer | Grant or award | +30,000 | 139,468 | ||
| 2022-05-02 | Rozov Yadin Director | Grant or award | +4,500 | 4,500 | ||
| 2022-05-02 | Rozov Yadin Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-21 | RAKIN KEVIN Director | Sale | −10,000 | $9.41 | $94K | 46,661 |
| 2022-02-17 | RAKIN KEVIN Director | Option exercise | +6,667 | $4.80 | $32K | 59,671 |
| 2022-02-17 | RAKIN KEVIN Director | Shares withheld for taxes | −3,010 | $10.63 | $32K | 56,661 |
| 2022-02-17 | RAKIN KEVIN Director | Option exercise · Stock Option (right to buy) | −6,667 | 0 | ||
| 2022-02-11 | RAKIN KEVIN Director | Gift | −5,000 | 53,004 | ||
| 2022-02-11 | RAKIN KEVIN Director | Gift | −5,000 | 47,004 | ||
| 2022-01-09 | Derovan Netanel Chief Legal Officer | Grant or award | +18,000 | 18,000 | ||
| 2022-01-09 | Derovan Netanel Chief Legal Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 |
Page 8 of 9 · 170 trades